Sheila Gujrathi Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Sheila Gujrathi is of Janux Therapeutics, Inc.. Currently has a direct ownership of 118,889 shares of JANX, which is worth approximately $3.1 Million. The most recent transaction as insider was on Jun 11, 2025, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 119K
3.26% 3M change
7.56% 12M change
Total Value Held $3.1 Million

Sheila Gujrathi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
3,750 Added 3.06%
118,889 Common Stock
Nov 05 2024
BUY
Other acquisition or disposition
-
4,611 Added 3.85%
115,139 Common Stock
Jun 26 2024
BUY
Grant, award, or other acquisition
-
2,500 Added 2.21%
110,528 Common Stock
Feb 29 2024
BUY
Other acquisition or disposition
-
2,986 Added 2.69%
108,028 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
VTYX
Ventyx Biosciences, Inc. Healthcare
SG

Sheila Gujrathi

San Diego, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX